Neuranics Raises $700K in Seed Round Led by Inflection Point Ventures

Neuranics, a healthcare diagnostics startup, has developed a blood analyzer that delivers complete blood count (CBC) results in under 10 minutes using just a finger-prick sample, with no need for liquid reagents or extra maintenance. The $700K raised in a seed round led by Inflection Point Ventures will support technology development and clinical validation, aiming for commercial production after CDSCO licensing. Neuranics has reached significant milestones, including receiving a test license, ethical approval, and progressing through clinical trials. Their device aims to provide faster, more accessible healthcare by delivering immediate results, improving patient outcomes, and reducing healthcare costs.

Dr. Megha Sharma, MD Pathologist and Chief Medical Evangelist at Neuranics says, “Our point-of-care CBC analyzer represents a significant leap forward in diagnostic convenience and accessibility. By utilizing a simple finger-prick capillary blood sample. We have effectively eliminated the need for traditional venipuncture, making blood testing faster, less invasive, and more patient-friendly. This technology empowers healthcare providers to deliver immediate, actionable insights, even in resource-limited settings, ultimately improving patient outcomes especially in Primary health care centres for screening and at emergency setups for triage.”

Praveen Kumar, Co-founder & CEO of Neuranics, says, “We are re-imagining how we approach diagnostics by bringing instant, accurate blood analysis closer to the patient without compromising on the quality. Our technology empowers clinicians with real-time data, transforming care delivery and elevating patient outcomes. By leveraging AI on de-identified pathological imaging data generated by our analyzer, we aim to set a new gold standard for national screening programs. This innovative technology will elevate healthcare quality in India and establish the country as a global leader in point of care blood analyser. We thank IPV for being with us in this journey. Working with IPV has been a streamlined and transformative experience. Their investment and guidance have empowered us to scale faster, innovate further, and bring our vision to life. IPV's efficient processes and industry connections have been instrumental in our journey.”